Prostate cancer is the second most common cancer in ... the edges of 85% of the most radiologically aggressive prostate lesions. Tumors with a larger volume, as estimated by the AI model, were ...

A recent study reveals that immunosuppression, or reduced immune response, in prostate cancer is associated with a ...

The PSA test has been the gold-standard treatment for detecting prostate cancer, but key shortcomings have prevented national ...

Every so often there is an urgent call for a national prostate cancer screening program to be introduced, usually following ...

Using AI to Measure Prostate Cancer Lesions Could Aid Diagnosis and Treatment Oct. 29, 2024 — Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are ...

Prostate cancer is the most commonly diagnosed noncutaneous neoplasm in men in the United States and is the second leading cause of cancer mortality. It poses diagnostic challenges in day-to-day ...

Prostate cancer is the most common non-skin cancer ... body radiation therapy allow precise targeting of malignant lesions, reducing damage to adjacent tissue and organs. These technologies ...